Plain-English translation of NCT06072430 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether , a new experimental medication, can safely and effectively raise blood pressure in patients with septic shock. Septic shock is a life-threatening condition that occurs when a severe infection causes the body's blood pressure to drop dangerously low, even after doctors try to fix it with IV fluids. This medication is designed to help restore healthy blood pressure when standard treatments aren't working.
Septic shock is a medical emergency, and when the medication fails to respond to fluids alone, patients need other options quickly to prevent organ damage and death. This trial exists to see whether this new treatment can help save lives when traditional approaches fall short.
If you qualify and agree to participate, you will receive the experimental medication as part of your septic shock treatment in the hospital. You will be monitored closely by medical staff, and your blood pressure and other vital signs will be tracked regularly. A safety review board will oversee the study to ensure all participants are being protected. The exact duration and number of visits will depend on your medical condition and recovery.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
United States